376 related articles for article (PubMed ID: 20086245)
21. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
Masamha CP; Albrecht TR; Wagner EJ
J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
23. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
24. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
25. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Sun F; Fu H; Liu Q; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
FEBS Lett; 2008 Apr; 582(10):1564-8. PubMed ID: 18406353
[TBL] [Abstract][Full Text] [Related]
27. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
Rosenwald A; Wright G; Wiestner A; Chan WC; Connors JM; Campo E; Gascoyne RD; Grogan TM; Muller-Hermelink HK; Smeland EB; Chiorazzi M; Giltnane JM; Hurt EM; Zhao H; Averett L; Henrickson S; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Montserrat E; Bosch F; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Fisher RI; Miller TP; LeBlanc M; Ott G; Kvaloy S; Holte H; Delabie J; Staudt LM
Cancer Cell; 2003 Feb; 3(2):185-97. PubMed ID: 12620412
[TBL] [Abstract][Full Text] [Related]
28. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
[TBL] [Abstract][Full Text] [Related]
29. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
Xia Z; Liu F; Zhang J; Liu L
PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825
[TBL] [Abstract][Full Text] [Related]
30. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
[TBL] [Abstract][Full Text] [Related]
33. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
Chen RW; Bemis LT; Amato CM; Myint H; Tran H; Birks DK; Eckhardt SG; Robinson WA
Blood; 2008 Aug; 112(3):822-9. PubMed ID: 18483394
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of microRNA-637 Increases Risk of Hypoxia-Induced Pulmonary Hypertension by Modulating Expression of Cyclin Dependent Kinase 6 (CDK6) in Pulmonary Smooth Muscle Cells.
Sang HY; Jin YL; Zhang WQ; Chen LB
Med Sci Monit; 2016 Oct; 22():4066-4072. PubMed ID: 27794186
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.
Afanasyeva EA; Mestdagh P; Kumps C; Vandesompele J; Ehemann V; Theissen J; Fischer M; Zapatka M; Brors B; Savelyeva L; Sagulenko V; Speleman F; Schwab M; Westermann F
Cell Death Differ; 2011 Jun; 18(6):974-84. PubMed ID: 21233845
[TBL] [Abstract][Full Text] [Related]
36. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.
Tang L; Chen F; Pang EJ; Zhang ZQ; Jin BW; Dong WF
Oncol Rep; 2015 Apr; 33(4):1707-16. PubMed ID: 25682742
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
Gu JF; Liu SG; Pan Q; Qin F; Li YY
Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
